Systemic lupus erythematosus concurrent with COVID-19: is platelet the
right target?
Abstract
In December 2019, Coronavirus disease 2019 (COVID-19), caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is widely spread
and causes a critical threat to clinical burden and public healthcare.
The outbreak of COVID-19 has aroused widespread concern in the
rheumatology community.